SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Clinical trials for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MS drug tolebrutinib tested for Long-Term safety in 2,500 patients
Disease control OngoingThis study looks at the long-term safety of the drug tolebrutinib in adults with multiple sclerosis (MS). It includes 2,500 people who have already taken part in earlier trials of this drug. Researchers will track side effects and check if the drug continues to help control the d…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Diet and calorie cutting may ease MS symptoms, study says
Symptom relief OngoingThis study looks at whether eating a better diet and cutting calories can improve physical function, thinking, pain, fatigue, mood, and anxiety in 100 adults with multiple sclerosis. Participants are overweight or obese and have relapsing-remitting or secondary progressive MS. Re…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 04, 2026 16:21 UTC